- Home
- GEG vs IMRX Comparison
GEG vs IMRX Comparison
Compare GEG & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- IMRX
- Stock Information
- Founded
- GEG 1994
- IMRX 2008
- Country
- GEG United States
- IMRX United States
- Employees
- GEG N/A
- IMRX N/A
- Industry
- GEG Computer Software: Prepackaged Software
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- GEG Technology
- IMRX Health Care
- Exchange
- GEG Nasdaq
- IMRX Nasdaq
- Market Cap
- GEG 60.4M
- IMRX 68.4M
- IPO Year
- GEG N/A
- IMRX 2021
- Fundamental
- Price
- GEG $2.07
- IMRX $3.45
- Analyst Decision
- GEG
- IMRX Strong Buy
- Analyst Count
- GEG 0
- IMRX 4
- Target Price
- GEG N/A
- IMRX $13.25
- AVG Volume (30 Days)
- GEG 9.8K
- IMRX 2.9M
- Earning Date
- GEG 08-28-2025
- IMRX 08-05-2025
- Dividend Yield
- GEG N/A
- IMRX N/A
- EPS Growth
- GEG N/A
- IMRX N/A
- EPS
- GEG N/A
- IMRX N/A
- Revenue
- GEG $19,626,000.00
- IMRX N/A
- Revenue This Year
- GEG N/A
- IMRX N/A
- Revenue Next Year
- GEG N/A
- IMRX N/A
- P/E Ratio
- GEG N/A
- IMRX N/A
- Revenue Growth
- GEG 64.34
- IMRX N/A
- 52 Week Low
- GEG $1.70
- IMRX $1.00
- 52 Week High
- GEG $2.33
- IMRX $3.87
- Technical
- Relative Strength Index (RSI)
- GEG 44.46
- IMRX 67.77
- Support Level
- GEG $1.96
- IMRX $2.29
- Resistance Level
- GEG $2.15
- IMRX $3.87
- Average True Range (ATR)
- GEG 0.09
- IMRX 0.47
- MACD
- GEG -0.02
- IMRX 0.08
- Stochastic Oscillator
- GEG 29.73
- IMRX 80.89
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.